Salesforce at $229: One Of The Most Unpredictable AI Plays There Is
Salesforce just delivered a massive earnings beat, sent analyst targets soaring, and still managed to lose ground against the broader market. Something about the AI story is not adding up, and the next two quarters will force a reckoning.
Salesforce (NYSE:CRM | CRM Price Prediction) trades at $228.97. The stock keeps swinging hard in both directions no matter how strong the reported numbers look. CNBC recently described the shares as sitting at the epicenter of AI confusion.
Salesforce leads the market for customer relationship management software and now wants to be the system enterprises use to run AI agents through Agentforce. Its latest quarter brought non-GAAP EPS of $5.90 against a $3.27 estimate, and revenue of $11.35 billion. Shares jumped 22.58% on earnings day, then fell 10.61% over the next 30 days.
Agentforce Momentum Meets a 14x Forward Earnings Multiple
Agentforce ARR exceeded $1.5 billion, up over 240%, and combined Agentforce and Data 360 ARR reached nearly $3.9 billion. Current RPO rose 14% to $33.5 billion. The stock still trades at a forward P/E of 14 with a free cash flow yield of 7.64%.
Management raised fiscal 2027 revenue guidance to $46.1 billion to $46.4 billion and non-GAAP EPS guidance to $16.67 to $16.71. Analysts followed, with 48 upward revisions and zero downward over 30 days. A buyback cut diluted shares to 821 million from 962 million.
Earnings Beats Keep Fading While Next Year’s Estimates Soften
Salesforce has delivered six consecutive EPS beats, yet the stock is down 12.9% year to date. The latest beat contained about $2.53 per share of investment profits, and operating income stayed flat at $2.33 billion. Restructuring charges rose to $94 million from $4 million.
The consensus for fiscal 2028 EPS is $16.02, below the fiscal 2027 figure of $16.75. The January quarter drew 32 downward revisions versus 6 upward. Cash flow growth is expected to only 4% to 5%. Its headless strategy, where “people don’t have to come to Salesforce to get work done,” could also weaken seat-based pricing power.
Strong Demand, Unproven Monetization Model
Net new AOV growth was the strongest in four years, and attrition sits near record lows. Those figures point to durable demand. AI pricing, though, still includes per-user, per-agent, consumption and outcome-based models, and management admitted to “continued volatility in overall license revenue.”
Two items will decide it: the promised second-half organic reacceleration and smooth completions of the Contentful and Fin deals. Third-quarter guidance calls for revenue of $11.42 billion to $11.5 billion and cRPO growth near 14%.
Wall Street Sees 24% Upside That the Market Keeps Ignoring
The average analyst target of $283.36 implies about 23.75% upside. Among 55 analysts:
- Strong Buy: 6
- Buy: 32
- Hold: 15
- Strong Sell: 2
Targets are one input and guarantee nothing. Over the past year, Salesforce fell 5.79% while the S&P 500 gained 16%. Year to date, the index is up 14.17%. The 52-week range of $146.06 to $267.80 shows how much the stock has moved.
Salesforce Needs AI to Show Up in Organic Growth
At $228.97, Salesforce faces a key test.
The valuation is cheap, but cheap stocks can stay cheap. After each of the last two quarterly reports, the stock fell more than 10% within 30 days. That pattern suggests investors see the AI story as unproven.
A stronger outlook would require third-quarter organic revenue growth at the top of guidance, steady cRPO growth and stable fiscal 2028 estimates. A weaker outlook would follow a missed reacceleration or slipping integration progress. The next one or two quarters will test that theory.
Salesforce trades at a low multiple, and Agentforce must lift organic growth to change the market’s view.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
